Human mesenchimal stem cells transplant failed to restore vasodilator potential in vascular tissues from diabetic rats but succeeded in spontaneously hypertensive rats

Soloviev, A. I.; Ivanova, I.; Novokhatska, T.; Klymenko, K.
March 2014
Proceedings of the Physiological Society;2014, p306P
Conference Proceeding
An abstract of the article "Human mesenchimal stem cells transplant failed to restore vasodilator potential in vascular tissues from diabetic rats but succeeded in spontaneously hypertensive rats" by A. I. Soloviev, I. Ivanova, T. Novokhatska and K. Klymenko is presented.


Related Articles

  • Tell Me More. Mettenburg, Julie // Countdown;Winter2000, Vol. 21 Issue 1, p40 

    Provides answers to readers' questions about diabetes. Barriers in the consideration of stem cell transplantation as a possible cure for diabetes; Research about genes called HLA markers which are associated with risk for diabetes.

  • Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Beilhack, Georg F.; Scheffold, Yolanda C.; Weissman, Irving L.; Taylor, Cariel; Jerabek, Libuse; Burge, Matthew J.; Masek, Marilyn A.; Shizuru, Judith A. // Diabetes;Jan2003, Vol. 52 Issue 1, p59 

    Purified hematopoietic stem cells (HSCs) were transplanted into NOD mice to test whether development of hyperglycemia could be prevented. Engraftment of major histocompatibility complex-mismatched HSCs was compared with bone marrow (BM) grafts. HSCs differed from BM because HSCs were more...

  • Stem cells: Diabetes reversed after transplant.  // Nature;1/8/2015, Vol. 517 Issue 7533, p125 

    The article discusses a study published in "Cell Stem Cell" which demonstrated how targeting specific immune cells can help prevent the rejection of transplanted stem cell-based pancreatic cells in diabetic mice.

  • Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat. Qing-Yu Dong; Li Chen; Guan-Qi Gao; Lei Wang; Jun Song; Bo Chen; Yu-Xin Xu; Lei Sun // Clinical & Investigative Medicine;Dec2008, Vol. 31 Issue 6, pE328 

    Background: Bone marrow-derived mesenchymal stem cells (BM-MSCs) are multipotent stroma cells which can provide a potential therapy for diabetes mellitus. But the mechanism is still controversial. Also, the status of BM-MSCs under hyperglycemia is not known. In the present study, we investigated...

  • FOOT CARE--LOWER EXTREMITIES.  // Diabetes;Jun 2014 Supplement, pA162 

    The article presents abstracts of studies related to diabetic foot ulcer, which include the effects of transplanting allogeneic rat adipose-derived-stem-cells (rADSC) sheets with artificial dermis on neovascularization and wound closure in full-thickness skin defects in diabetic rats, and the...

  • Testicular function in patients with type 1 diabetes treated with high-dose CY and autologous hematopoietic SCT. Leal, A M O; Oliveira, M C; Couri, C E B; Moraes, D A; Stracieri, A-BPL; Pieroni, F; Soares, R D A; Barros, G N; Simões, B P; Foss, M C; Voltarelli, J C // Bone Marrow Transplantation;Mar2012, Vol. 47 Issue 3, p467 

    A letter to the editor is presented in response to an article about patients with type 1 diabetes treated with autologous hematopoietic SCT (AHSCT).

  • Endocrine complications after busulphan and cyclophosphamide based hematopoietic stem cell transplant: A single tertiary care centre experience. Gundgurthi, Abhay; Garg, M. K.; Nair, Velu; Pakhetra, Rajeev; Das, Satyanarayan; Sharma, Sanjeevan; Dutta, Manoj K.; Kharb, Sandeep; Kapoor, Rajan // Indian Journal of Endocrinology & Metabolism;Sep/Oct2013, Vol. 17 Issue 5, p855 

    Introduction: Endocrine complications are common after hematopoietic stem cell transplant (HSCT). Although HSCT is performed at various centers in India, no study is available for endocrine dysfunctions among them. This study was carried out with the objective to evaluate endocrine dysfunction...

  • Nature Genetics: A new approach to treating type I diabetes? Gut cells transformed into insulin factories.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article focuses on a new study led by Columbia researchers which suggests the use of patient's intestinal cells in making insulin for treatment against type I diabetes and use of this insulin as a replacement of stem cell replacement therapy.

  • Charlie's Angel. Lewinson, Rachael // Countdown;Fall2004, Vol. 25 Issue 4, Special Section p12 

    Interviews Anne Seidel, a diabetic mom who also has a diabetic son. Changes brought by her decision to put herself in a waiting list for islet transplantation; Age when she was diagnosed with diabetes; Diabetes management when Seidel was a child; Involvement with the Juvenile Diabetes Research...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics